Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Rovi Contract Manufacturing
Rovi Contract Manufacturing
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
ROVI CM installs new hard capsules filling line
Capacity to fill granulate, powder and pellets, with an annual capacity of 500 million capsules
Research & Development
Novavax terminates negotiations with ROVI Pharmaceuticals
US biotech Novavax has ended talks aimed at negotiating the terms of a collaboration with Spanish drugmaker ROVI Pharmaceuticals to develop Novavax\'s virus-like-particle (VLP)-based vaccines against influenza.
Regulatory
Rovi wins Spanish contract for flu vaccines
<p>The Spanish government has awarded a Euro 60m contract to Laboratorios Farmaceuticos Rovi to produce pandemic and seasonal flu vaccines based on a technology developed by US firm Novavax. </p>
Subscribe now